Citius Oncology, Inc. CTOR Unrecorded Unconditional Purchase Obligation
Unrecorded Unconditional Purchase Obligation at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PurchaseObligationDueInNextTwelveMonths.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s unrecorded unconditional purchase obligation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s unrecorded unconditional purchase obligation?
- Citius Oncology, Inc. (CTOR) reported unrecorded unconditional purchase obligation of $4M in Q1 2026.
- How has Citius Oncology, Inc.'s unrecorded unconditional purchase obligation changed year-over-year?
- Citius Oncology, Inc.'s unrecorded unconditional purchase obligation increased by 37.9% year-over-year, from $2.9M to $4M.
- What does unrecorded unconditional purchase obligation mean?
- Contractual commitments to purchase goods or services that are legally binding but have not yet been recognized as liabilities on the balance sheet because the goods or services have not been received. These obligations represent future cash outflows that are essential for ongoing operations.